Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Maintains Buy on MaxLinear, Lowers Price Target to $50

Needham analyst Quinn Bolton maintains MaxLinear (NASDAQ:MXL) with a Buy and lowers the price target from $53 to $50.

byBenzinga Newsdesk

October 26, 2022

1 minute read

Needham analyst Quinn Bolton maintains MaxLinear (NASDAQ:MXL) with a Buy and lowers the price target from $53 to $50.

Coda Octopus Clocks Q3 Revenue Growth of 8%

By Anusuya Lahiri

Today, 4:57 AM

Coda Octopus Group Inc (NASDAQ:CODA) reported third-quarter FY21 revenue growth of 7.9% year-on-year to $5.827 million, marginally ahead of the consensus…

CODA

Piper Sandler Initiates Coverage On Day One Biopharmaceutical with Overweight Rating, Announces Price Target of $44

By Benzinga Newsdesk

Today, 4:57 AM

Piper Sandler analyst Erinn Murphy initiates coverage on Day One Biopharmaceutical (NASDAQ:DAWN) with a Overweight rating and announces Price Target of $44.

DAWN